MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Quanterix Corp

Închisă

SectorSănătate

6.5 -1.66

Rezumat

Modificarea prețului

24h

Curent

Minim

6.39

Maxim

6.6

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+13.12% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

62M

300M

Deschiderea anterioară

8.16

Închiderea anterioară

6.5

Sentimentul știrilor

By Acuity

41%

59%

146 / 372 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 ian. 2026, 23:11 UTC

Câștiguri

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ian. 2026, 22:55 UTC

Principalele dinamici ale pieței

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ian. 2026, 21:39 UTC

Principalele dinamici ale pieței

Raytheon Down Following Trump Post Criticizing Company

7 ian. 2026, 20:13 UTC

Principalele dinamici ale pieței

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ian. 2026, 20:03 UTC

Principalele dinamici ale pieței

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ian. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 ian. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ian. 2026, 23:42 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ian. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ian. 2026, 23:29 UTC

Achiziții, Fuziuni, Preluări

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ian. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ian. 2026, 22:46 UTC

Câștiguri

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ian. 2026, 22:45 UTC

Câștiguri

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ian. 2026, 22:43 UTC

Achiziții, Fuziuni, Preluări

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ian. 2026, 22:42 UTC

Câștiguri

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ian. 2026, 22:41 UTC

Câștiguri

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ian. 2026, 22:41 UTC

Câștiguri

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ian. 2026, 22:40 UTC

Principalele dinamici ale pieței

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ian. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ian. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ian. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 ian. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ian. 2026, 21:22 UTC

Achiziții, Fuziuni, Preluări

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ian. 2026, 21:18 UTC

Achiziții, Fuziuni, Preluări

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ian. 2026, 21:05 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ian. 2026, 20:29 UTC

Achiziții, Fuziuni, Preluări

AbbVie Near Deal for Revolution Medicines -- Update

7 ian. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ian. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ian. 2026, 19:48 UTC

Principalele dinamici ale pieței

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

13.12% sus

Prognoză pe 12 luni

Medie 7.5 USD  13.12%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

146 / 372 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat